BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27122485)

  • 1. Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses.
    Clements JD; Freytag LC
    Clin Vaccine Immunol; 2016 Jun; 23(6):438-441. PubMed ID: 27122485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
    Teunissen MB; Haniffa M; Collin MP
    Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vaccine development strategies for inducing mucosal immunity.
    Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
    Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adjuvants in the development of mucosal vaccines.
    Vajdy M; Singh M
    Expert Opin Biol Ther; 2005 Jul; 5(7):953-65. PubMed ID: 16018740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISCOMATRIXâ„¢ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.
    Timothy AA; Tokanovic A; Snibson KJ; Edwards SJ; Pearse MJ; Scheerlinck JP; Sutton P
    Hum Vaccin Immunother; 2015; 11(2):377-85. PubMed ID: 25692970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric vaccines for the developing world: a challenge for mucosal immunology.
    Czerkinsky C; Holmgren J
    Mucosal Immunol; 2009 Jul; 2(4):284-7. PubMed ID: 19421181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of nanoparticle-based vaccines.
    Marasini N; Skwarczynski M; Toth I
    Ther Deliv; 2017 Jan; 8(3):151-167. PubMed ID: 28145824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic vaccines].
    Logunov DIu; NaroditskiÄ­ BS; Gintsburg AL; Vorob'ev AA
    Vestn Ross Akad Med Nauk; 2005; (1):14-9. PubMed ID: 15715149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal adjuvants.
    Harandi AM; Medaglini D
    Curr HIV Res; 2010 Jun; 8(4):330-5. PubMed ID: 20353395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective immune responses at respiratory mucosal sites.
    Park SC; Wiest MJ; Yan V; Wong PT; Schotsaert M
    Hum Vaccin Immunother; 2024 Dec; 20(1):2368288. PubMed ID: 38953250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of vaccine adjuvanticity, vaccine activity, protective immunity and disease in human infectious disease and cancer.
    Ottenhoff THM
    Semin Immunol; 2018 Oct; 39():1-3. PubMed ID: 30318307
    [No Abstract]   [Full Text] [Related]  

  • 16. New advances in mucosal vaccination.
    Ranasinghe C
    Immunol Lett; 2014 Oct; 161(2):204-6. PubMed ID: 24462961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of secretory antibodies in the defence against infections.
    Brandtzaeg P
    Int J Med Microbiol; 2003 Apr; 293(1):3-15. PubMed ID: 12755363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of local antibody production: parenteral or mucosal vaccination?
    Bouvet JP; Decroix N; Pamonsinlapatham P
    Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can infants be protected by means of maternal vaccination?
    Esposito S; Bosis S; Morlacchi L; Baggi E; Sabatini C; Principi N
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():85-92. PubMed ID: 22862749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccine design and delivery.
    Woodrow KA; Bennett KM; Lo DD
    Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.